Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

MDB Capital Holdings, LLC - Class A common (NQ:MDBH)

3.051 +0.001 (+0.02%)

Streaming Delayed Price Updated: 9:59 AM EDT, Jul 29, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,302
Open	3.051
Bid (Size)	3.050 (700)
Ask (Size)	3.260 (3,300)
Prev. Close	3.050
Today's Range	3.051 - 3.051
52wk Range	2.450 - 4.800
Shares Outstanding	5,138,632
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

What Is OpenAI Actually Patenting? PatentVest Pulse Analyzes OpenAI's Patent Portfolio

July 23, 2026

New PatentVest Pulse report reveals how OpenAI's published patent portfolio maps its AI product strategy across conversational AI, AI agents, generative media, developer platforms, personalization, and...

From PatentVest, Inc.

Via GlobeNewswire

PatentVest Publishes New IP Legal Insights Article Examining Why Patent Prosecution Is Ready for AI

July 02, 2026

From PatentVest, Inc.

Via GlobeNewswire

Performance

YTD	-12.8%	-12.8%
1 Month	-3.8%	-3.8%
3 Month	-16.7%	-16.7%
6 Month	-6.7%	-6.7%
1 Year	-29.1%	-29.1%

More News

PatentVest Releases New PatentVest Pulse Report Exploring the Strategic Shift Beyond GLP-1

June 30, 2026

From PatentVest, Inc.

Via GlobeNewswire

PatentVest to Present at Planet MicroCap Las Vegas on June 17

June 15, 2026

From PatentVest, Inc.

Via GlobeNewswire

New PatentVest Pulse Report Maps the Emerging Muscle-Preservation Category Expanding the GLP-1 Opportunity

June 04, 2026

From PatentVest, Inc.

Via GlobeNewswire

MDB Capital to Present at Planet MicroCap Las Vegas 2026 Along with Subsidiary PatentVest and Portfolio Company Buda Juice

June 03, 2026

From MDB Capital Holdings, LLC

Via GlobeNewswire

PatentVest Launches New Case Studies Section Featuring Strategic AI IP Engagement with Docana

May 19, 2026

From PatentVest, Inc.

Via GlobeNewswire

New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity Market

May 08, 2026

From PatentVest, Inc.

Via GlobeNewswire

Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started

April 29, 2026

From PatentVest, Inc.

Via GlobeNewswire

MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Letter

March 31, 2026

From MDB Capital Holdings, LLC

Via GlobeNewswire

PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment

March 31, 2026

From PatentVest, Inc.

Via GlobeNewswire

PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork

March 30, 2026

From PatentVest, Inc.

Via GlobeNewswire

PatentVest Announces Life Seal Vascular Partnership, Takes Equity Stake in Exchange for IP Intelligence Services

March 30, 2026

From PatentVest, Inc.

Via GlobeNewswire

MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time

March 23, 2026

From MDB Capital Holdings, LLC

Via GlobeNewswire

PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics

March 11, 2026

From PatentVest, Inc.

Via GlobeNewswire

PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race

February 26, 2026

From PatentVest, Inc.

Via GlobeNewswire

MDB Capital Holdings Announces Transitions In Its Board of Directors

February 02, 2026

From MDB Capital Holdings, LLC

Via GlobeNewswire

PatentVest Releases New Report on the IP Battle Shaping the $1.8 Trillion Space Economy

January 14, 2026

From PatentVest, Inc.

Via GlobeNewswire

MDB Capital Holdings Provides Third Quarter 2025 Update

November 20, 2025

From MDB Capital Holdings, LLC

Via GlobeNewswire

MDB Capital Holdings to Host Third Quarter 2025 Update Conference Call on Thursday November 20, 2025, at 4:30 p.m. Eastern Time

November 11, 2025

From MDB Capital Holdings, LLC

Via GlobeNewswire

New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $133B Cardiac Diagnostics Market

October 28, 2025

From PatentVest, Inc.

Via GlobeNewswire

PatentVest Welcomes Dr. Sarah Cork as Senior Patent Attorney, Expanding Life Sciences IP Leadership

September 24, 2025

From PatentVest, Inc.

Via GlobeNewswire

MDB Capital Holdings Plans PatVest IPO ↗

August 27, 2025

Via The Motley Fool

MDB Capital Holdings Provides Second Quarter 2025 Update

August 27, 2025

From MDB Capital Holdings, LLC

Via GlobeNewswire

PatentVest and Docana Announce Strategic Partnership to Accelerate IP Strategy and AI Innovation

August 27, 2025

From PatentVest, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is MDB Capital Holdings, LLC - Class A common publicly traded?

Yes, MDB Capital Holdings, LLC - Class A common is publicly traded.

What exchange does MDB Capital Holdings, LLC - Class A common trade on?

MDB Capital Holdings, LLC - Class A common trades on the Nasdaq Stock Market

What is the ticker symbol for MDB Capital Holdings, LLC - Class A common?

The ticker symbol for MDB Capital Holdings, LLC - Class A common is MDBH on the Nasdaq Stock Market

What is the current price of MDB Capital Holdings, LLC - Class A common?

The current price of MDB Capital Holdings, LLC - Class A common is 3.051

When was MDB Capital Holdings, LLC - Class A common last traded?

The last trade of MDB Capital Holdings, LLC - Class A common was at 07/29/26 09:59 AM ET

What is the market capitalization of MDB Capital Holdings, LLC - Class A common?

The market capitalization of MDB Capital Holdings, LLC - Class A common is 15.68M

How many shares of MDB Capital Holdings, LLC - Class A common are outstanding?

MDB Capital Holdings, LLC - Class A common has 16M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.